This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Fresenius notes NPAs settling FCPA probes, strengthened compliance efforts

( March 29, 2019, 19:30 GMT | Official Statement) -- MLex Summary: Fresenius Medical Care announced it has intered into nonprosecution agreements with the US Department of Justice and Securities and Exchange Commission to settle investigations into Foreign Corrupt Practices Act violations today, noting in its press release that said it has strengthened its compliance programs and internal controls since the probes began.  The German company agreed to pay US authorities $231 million and to retain an independent compliance monitor. Fresenius also said that it had already reserved funds in anticipation of a settlement and that the FCPA resolutions will not affect its 2019 and 2020 financial results.Statement follows:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections